AFRM vs PRLD · P/E 590, rev $3.22B vs rev $6.5M
Affirm Holdings Inc (AFRM) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the AFRM and PRLD stock pages for the full models.
Not investment advice.